Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Swedish Financial Supervisory Authority’s preliminary assessment of Resurs Bank’s credit assessments

Resurs Bank AB (“Resurs”) is subject to an investigation by the Swedish Financial Supervisory Authority (Finansinspektionen) for the purpose of examining whether the bank’s credit assessments comply with Chapters 6 and 12 of the Swedish Consumer Credit Act (2010:1846) and Finansinspektionen’s general guidelines regarding consumer credit (FFFS 2014:11). Today, Resurs received letter from Finansinspektionen according to which Finansinspektionen’s preliminary assessment is that Resurs Bank does not base its credit assessments on adequate data and thus is non-compliant with the Consumer

Latour acquires Consens GmbH

Investment AB Latour (publ) has, through its wholly-owned subsidiary S+S Regeltechnik GmbH, part of business area Bemsiq, signed an agreement to acquire Consens GmbH. Bemsiq is a group of innovative and fast-growing companies providing products in building automation and metering. Consens is a developer of devices, sensors, components, testing technology and systems for humidity, temperature, and air quality. The company was founded in 1998 and has 13 employees with head office and manufacturing in Thüringen, Germany. Net sales are estimated at 2.9 MEUR in 2021 with a profit level well

Bittium Corporation: The Finnish Defence Forces Order Bittium TAC WIN™ System’s Products Based on a Framework Agreement on the Purchase of the Products

Stock exchange release Free for publication on February 8, 2022 at 6.00 pm (CET+1) Bittium Corporation: The Finnish Defence Forces Order Bittium TAC WIN™ System’s Products Based on a Framework Agreement on the Purchase of the Products In Oulu, Finland, February 8, 2022 – The Finnish Defence Forces order Bittium Tactical Wireless IP Network™ (TAC WIN) system’s products based on a Framework Agreement on the purchase of the products. The value of the purchase order is approximately EUR 8.8 million (excl. VAT). The ordered tactical routers and radio heads are related to several ongoing

Sawlog supply in US South tightening and a surplus of small logs and residues creates opportunities for pulp and wood pellet expansion

The US South’s softwood industry has enormous potential for a variety of reasons. The region has a significant forest resource with room for expansion, low and stable wood costs, and a thriving lumber and pellet manufacturing sector. The local forest industry is set to grow in the coming years and play a more prominent role in regional and global forest product markets. This expansion will lead to a tighter log market, but growth will still exceed harvests (drain) in most states. Longer-term, the drain could overtake growth in some states unless the productive forest area expands, harvest

Evolution global online event showcases 25 new games, part of its ‘GREAT 88’ for 2022

[PR] Evolution today hosted an online event (3pm CET, Tuesday 8 February) at which it showcased 25 new online casino games from its Group brands – Evolution, NetEnt, Red Tiger, Ezugi, Big Time Gaming and DigiWheel. The 25 games are part of ‘THE GREAT 88’, an Evolution initiative that will see 88 games released by the Group in 2022.This first tranche of new games encompasses live casino, live game shows and slots titles. Amongst numerous exciting releases are several big-brand tie-ins for games from Evolution, NetEnt Red Tiger and Big Time Gaming, new homegrown titles, as well as sequels to

Veidekke ASA: To build more at Vollebekk in Oslo

OBOS Nye Hjem has awarded Veidekke the contract to build the Vollebekk Torgkvartal housing cooperative with 153 environmentally certified apartments, five shared apartments, a kindergarten, commercial premises and underground parking at Vollebekk in eastern Oslo. This is the sixth construction stage in the major project, and the design and build contract is valued at NOK 505 million excluding VAT.“We are very pleased to continue building at Vollebekk. OBOS has a culture that is a good fit with our own, and with one of Oslo’s best housing teams in place, I’m confident that this project will

Sectra wins four 2022 Best in KLAS awards in the US, Canada, and Asia/Oceania

Linköping, Sweden – February 8, 2022 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) announces that its radiology module for enterprise imaging, Sectra PACS, has won the prestigious customer satisfaction award Best in KLAS. It has been ranked number one by healthcare providers for the ninth consecutive year in the US, third consecutive year in Canada, and for a first-time in Asia/Oceania. The awards are given by the healthcare IT data and insights company KLAS Research in the 2022 Best in KLAS: Software and Services Report.Marie

PostNord paves the way with a new agenda for sustainable logistics

As a leading provider of parcel and logistics services, PostNord has a key role in Nordic business and society. Our ambition is to make everyday life easier and to be a leader in sustainable logistics. With a long history of systematic and successful sustainability programs, we have now adopted a new ambitious agenda to drive the transition of our industry.PostNord has defined three clear commitments regarding sustainable logistics: · We manifest climate leadership. · We care for our people. · We unleash the power of diversity. We manifest climate leadership To solve the

Conversion of Nightingale Health Plc’s Series A shares to Series B shares

Company release, 8 February 2022 at 4:00 p.m. (EET) The Board of Directors of Nightingale Health Plc (“Nightingale”) has in its meeting on November 8, 2021, approved a request of shareholders to convert 661,246 Series A shares of Nightingale to Series B shares in accordance with Article 5 in the Articles of Association. As a result of the conversion of shares, the number of the Nightingale’s Series A shares is 21,518,422, Series B shares is 37,880,735 and EMP shares is 1,482,580. The conversion does not affect the total amount of shares which is 60,881,737. The number of votes of

Electrolux valberedning föreslår omval av styrelsen

Stockholm, 8 februari 2022 Electrolux valberedning föreslår inför årsstämman den 30 mars omval av samtliga styrelseledamöter. Staffan Bohman föreslås väljas om till styrelseordförande och Petra Hedengran, Henrik Henriksson, Ulla Litzén, Karin Overbeck, Fredrik Persson, David Porter och Jonas Samuelson som ledamöter.Electrolux valberedning utgörs av Johan Forssell (ordförande), Investor AB, Carina Silberg, Alecta, Tomas Risbecker, AMF – Försäkring och Fonder, och Marianne Nilsson, Swedbank Robur Fonder. I valberedningen ingår också Staffan Bohman och Fredrik Persson, ordförande respektive

Electrolux Nomination Committee proposes re-election of board members

Stockholm, Sweden, February 08, 2022 In preparation for the Electrolux Annual General Meeting on March 30, Electrolux Nomination Committee has decided to propose the re-election of all board members. Staffan Bohman is proposed to be re-elected as Chairman of the Board of Directors, and Petra Hedengran, Henrik Henriksson, Ulla Litzén, Karin Overbeck, Fredrik Persson, David Porter and Jonas Samuelson as Board Members.The Nomination Committee comprises Johan Forssell (Chairman), Investor AB, Carina Silberg, Alecta, Tomas Risbecker, AMF – Försäkring och Fonder, and Marianne Nilsson, Swedbank

NextCell invests in CAR-T technology

NextCell Pharma AB ("NextCell" or the"Company") informs that FamiCordTx, a joint venture cell-gene biopharma company issues new share. The major shareholders, PBKM and NextCell will participate at 50% of their pro rata rights. For NextCell this results in an investment of approximately kEUR 160, whereas its ownership in FamiCordTx will change from 9,43% to 8,45% of the then shares.FamiCordTx S.A., raised PLN 16 million (approximatly MEUR 3,5) from a pre-IPO issue of shares •  The proceeds from the issue will be used to fund the Phase 1 clinical trials of CAR T (chimeric antigen receptor

Scandi Standard – Fourth quarter presentation

Scandi Standard will publish its report for the fourth quarter 2021 on Friday, 11 February 2022 at 07.30 CET.   Conference call at 08.3o CETThe Company will host a conference call for the financial community at 08.30 CET the same day. The conference call will be hosted by Otto Drakenberg, CEO and Julia Lagerqvist, CFO.  Dial in numbers:Sweden (Local) 010 884 80 16 United Kingdom 0800 640 6441 United Kingdom (Local) 020 3936 2999 All other locations +44 203 936 2999      Participant Access Code:  494008   The presentation used in the conference call

Share-based long-term incentive scheme 2022–2024 for the management and selected key employees of Nokian Tyres plc, and payments for share-based plans that ended in 2021

Nokian Tyres plc Stock Exchange Release February 8, 2022 at 3:25 p.m. The Board of Directors of Nokian Tyres plc has decided on a share-based long-term incentive scheme for the Company’s management and selected key employees for years 2022–2024 as a continuation to the earlier plans decided in 2019, 2020 and 2021. The decision includes Performance Share Plan 2022 (“PSP 2022”) as the main structure and Restricted Share Plan 2022 (“RSP 2022”) as a complementary structure. The purpose of the share-based incentive scheme is to align the goals of the Company’s shareholders and key

Observe Medical ASA – Approval and publication of the prospectus for the rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS STOCK EXCHANGE Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company") on 4 February 2022 regarding the extraordinary general meeting's approval of a rights issue of 25,714,286 new shares

ExpreS2ion provides an update on its novel breast cancer vaccine candidate ES2B-C001

Hørsholm, Denmark, February 8, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion" or the “Company”) announces constructive feedback from its scientific advice meeting pertaining to the therapeutic breast cancer vaccine candidate, ES2B-C001, with the Danish Medicines Agency (“DKMA”). Based on this feedback, ExpreS2ion plans to conduct an additional preclinical safety study in the first half of 2023, which will increase the robustness of the project’s preclinical data. Consequently, the Company is now aiming to file the clinical trial application for

Notice of Digia Plc’s Annual General Meeting 2022

Digia PlcStock exchange release8 February 2022 at 3:00 pmDigia Plc’s shareholders are invited to attend the Annual General Meeting, which will be held on Monday 21 March 2022 at 10:00 am at the company’s headquarters (Atomitie 2 A, 00370 Helsinki). The company’s shareholders (or their representatives) may only participate in the meeting and exercise their shareholder’s rights by voting in advance and by submitting any counterproposals and questions in advance. Instructions for shareholders can be found in section C of this invitation, “Instructions for meeting attendees”. The company’

Digia Plc Financial Statement Bulletin 2021

Digia PlcFinancial Statement Bulletin8 February 2022 at 3:00 pmA strong fourth quarter – full-year net sales rise by 12.1% with an EBITA margin of 11.4% October–December 2021 · Net sales: EUR 44.8 (37.9) million, up 18.2 per cent · Operating profit (EBITA): EUR 5.0 (4.6) million, up 7.8 per cent; EBITA margin: 11.1 (12.1) per cent of net sales · Operating profit: EUR 4.2 (4.1) million, up 3.8 per cent; operating margin: 9.4 (10.7) per cent of net sales · Earnings per share: EUR 0.13 (0.11) · Share buyback programme started 16 December January–December 2021 ·

Clinical trial in type 1 diabetes with Diamyd Medical's Remygen® is fully recruited

The investigator-initiated clinical trial ReGenerate-1 in type 1 diabetes with Diamyd Medical's investigational drug Remygen[®] (GABA) is now fully recruited with 35 patients. The participants will be followed for up to 9 months. Results are expected to be presented in the first quarter of 2023.“ReGenerate-1 includes patients who have had type 1 diabetes for many years,” says Per-Ola Carlsson, Professor at Uppsala University and Uppsala University Hospital, Sponsor of the trial. “The interest in participating has been great, and this is probably due to the fact that the trial is aimed at

Wärtsilä included in the Sustainability Yearbook for the ninth time in a row

The technology group Wärtsilä has for the ninth year in a row been included in the Sustainability Yearbook by S&P Global.   This year, only 716 companies with top scores were selected into the Yearbook out of the 7,500 that were assessed in the 2021 Corporate Sustainability Assessment (CSA). To be selected as a Yearbook member, companies must score within the top 15% of their industry. Wärtsilä’s relatively strongest areas within its industry were sustainability reporting, codes of business conduct, strategy for emerging markets and innovation management.   “We are proud to be

D-Orbit SpA has today placed an order with GomSpace for the P60 power systems and batteries

D-Orbit SpA has today placed an order with GomSpace for the P60 power systems and batteries. The total value of the order is 9 MSEK. Delivery is expected in Q2/Q3 2022. The GomSpace power system has been a critical component in ION Satellite Carrier, the orbital transportation vehicle designed, manufactured, and operated by D-Orbit. With this order, the cooperation will continue for the coming ION missions.ION is space vehicle able to deploy satellites into precise and independent orbital slots, allowing D-Orbit’s customers to start their missions faster and in optimal operational

New Study Shows Nearly 80 Percent of Companies Will Implement Conversational Customer Engagement to Improve Customer Experience

03_0122_Sinch_PR [New study details customer engagement and the importance of CPaaS platforms.] New study details customer engagement and the importance of CPaaS platforms. White paper showcases Sinch-sponsored study: more than half of enterprises surveyed are increasing investments in CPaaS to power conversational customer engagement STOCKHOLM and ATLANTA – February 8, 2022 – Nearly 80% of companies have or will implement conversational customer engagement — the practice of communicating interactively with customers from one digital channel to another while retaining context —

Nokian Tyres plc: Proposals by the Board of Directors to the Annual General Meeting 2022

Nokian Tyres plc Stock Exchange Release February 8, 2022 at 2:50 p.m. The Board of Directors of Nokian Tyres plc has decided that the Annual General Meeting will be held on Thursday, April 28, 2022 at 10.00 a.m. (EET) with exceptional meeting procedures based on the temporary legislative act to limit the spread of the Covid-19 pandemic (375/2021). The Company will publish the notice to the Annual General Meeting on March 31, 2022 at the latest with more detailed information on the participation and voting at the Annual General Meeting. In order to ensure the health and safety of the

Invitation to presentation of ChromoGenics Q4 and Year End Report for the financial year 2021

ChromoGenics published it’s Q4 and Year End Report for the financial year 2021, today February 8, 2022, and now invites to a presentation of the report. The presentation will be held on Wednesday, February 9 at 11.00 AM.The presentation will be held in Swedish by CEO Fredrik Fränding and it is possible to ask questions via a chat function during the presentation. The presentation will also be posted afterwards on ChromoGenics website. The Swedish presentation will be available here 

There are no items matching the current filter
There are no more items matching the current filter
Back to top